Jonathan Grim is an Oncology physician affiliated with Jazz Pharmaceuticals. OpenAlex indexes 20 publications with 723 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2006–2010 per NIH RePORTER. The latest:
- Mechanisms of tumor suppression by Fbw7
Fred Hutchinson Cancer Research Center
FY2010$140,535K08CA109124 - Mechanisms of tumor suppression by Fbw7
Fred Hutchinson Cancer Research Center
FY2009$140,535K08CA109124 - Mechanisms of tumor suppression by Fbw7
Fred Hutchinson Cancer Research Center
FY2009$136,565K08CA109124
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Stefan Faderl, MD
Jazz Pharmaceuticals
Robert Iannone, MD
Jazz Pharmaceuticals
Stefan Faderl
Jazz Pharmaceuticals
Wayne Macfadden, MD
Jazz Pharmaceuticals
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”